Abstract
In this chapter, we will link three important risk factors for heart disease: hypertension, atherosclerosis and dyslipidemia. Chronically elevated blood pressure, i.e., hypertension, increases the risk of ischemic heart disease, stroke, peripheral vascular disease and other CVDs. This is the most important preventable risk factor for premature death. The low intake of fruit and vegetables and whole grain fiber and high consumption of saturated fat and high-cholesterol diets can lead to hypercholesterolemia and atherosclerosis, especially in genetically predisposed individuals. Atherosclerosis is a chronic inflammatory disease caused by the accumulation of cholesterol-laden macrophages in the artery wall, i.e., it is based on dyslipidemia and an overreaction of the immune system. Accordingly, the susceptibility to CVDs is associated with genes affecting the serum levels of plasma lipids and lipoproteins. Furthermore, we will discuss the role of insulin resistance and obesity in the major metabolic tissues liver, skeletal muscle, pancreas and WAT causing the metabolic syndrome. The importance of inflammation and regulation of energy metabolism will be highlighted. The genetic risk for the metabolic syndrome overlaps with that of its major components obesity, T2D and dyslipidemia. However, like in these traits, common genetic variations can explain only a minor part of the disease risk. Therefore, we will present the important role of epigenetics in the origin and development of the metabolic syndrome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Additional Readings
Barroso I, McCarthy MI (2019) The genetic basis of metabolic disease. Cell 177:146–161
Drummond GR, Vinh A, Guzik TJ, Sobey CG (2019) Immune mechanisms of hypertension. Nat Rev Immunol 19:517–532
Hunter PM, Hegele RA (2017) Functional foods and dietary supplements for the management of dyslipidaemia. Nat Rev Endocrinol 13:278–288
Jensen MK, Bertoia ML, Cahill LE, Agarwal I, Rimm EB, Mukamal KJ (2014) Novel metabolic biomarkers of cardiovascular disease. Nat Rev Endocrinol (11):659–672
Tall AR, Yvan-Charvet L (2015) Cholesterol, inflammation and innate immunity. Nat Rev Immunol 15:104–116
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Carlberg, C., Ulven, S.M., Molnár, F. (2020). Heart Disease and the Metabolic Syndrome. In: Nutrigenomics: How Science Works. Springer, Cham. https://doi.org/10.1007/978-3-030-36948-4_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-36948-4_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-36947-7
Online ISBN: 978-3-030-36948-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)